 |
| New Client CWNM Up Over 16% |
|
 Hot Stock to Watch |
Company: Crown Marketing Pharmaceuticals (OTCQB: CWNM)
|
Last:
Price: 0.128
Change (%): + 0.018 (16.36)
Volume: 261,036 |
 |
Our patented and scientifically-proven technology aims not only to improve the safety and pharmacokinetics of controlled-release medication, but also to streamline the manufacturing process for existing facilities without significant upgrade investment.
Current CDDT processes, despite continual improvements, still rely on dissolvable coatings or hydrophilic matrix processes to deliver medication over a period of time. Coatings are only effective when they remain intact, causing a potential risk to the patient when cracks or breaks occur in a pill. Hydrophilic matrices, though more effective than traditional coatings, are created from an estimation of stomach acids and other fluids to break down the matrix, and their effectiveness is entirely dependent on each patient’s body matching these same estimates. Because no two patients are the same, even the most advanced time-release medications can cause potential spikes of toxicity or decreased bioavailability in different patients.
Crown Marketing Pharmaceuticals seeks to change that process entirely, providing for a more sustained and sustainable release of medication in each individual patient through our patented technology. Our process allows for the potential of a true 24-hour sustained-release product without the excessive overhead of chemical remanufacturing for matrix process medications, and without the risks associated with cracked or broken pill coatings.
Company Information Sheet
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
